Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST INDXX FUTURE ECONOMY METALS UCITS ETF 06.07.2026 METL LN IE000UDFKE13 175,002.00 USD 6,349,892.71 36.285 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest S&P 500 Dividend Aristocrats Target Income UCITS ETF 06.07.2026 KNG.LN IE000SNMGYT5 1,000,002.00 USD 21,175,695.18 21.176 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 06.07.2026 SCAR LN IE000BW2B3J3 50,002.00 USD 1,462,532.22 29.249 ...
-
Private Department of Sheikh Mohammed bin Khalid Al Nahyan Invests in MidOcean Energy and Forms Strategic Partnership with EIG
LONDON & WASHINGTON--(BUSINESS WIRE)--The Private Department of Sheikh Mohammed bin Khalid Al Nahyan (the “Private Department”) has today committed to invest $1.13bn in MidOcean Energy (“MidOcean” or the “Company”), a liquefied natural gas (LNG) company formed and managed by EIG. In parallel with the investment, the Private Department and EIG have established a strategic partnership focused on capital aggregation, investment origination, and the development of institutional investment opportuni...
-
Majority of Enterprises Hit by Executive Impersonation as C-Suite Becomes the Fastest-Growing Attack Surface
NEW YORK--(BUSINESS WIRE)--Outtake today released the 2026 State of Executive Impersonation Report, the industry's first report detailing where, how, and why executives are getting impersonated online. Drawn from a sample of 40 thousand impersonation alerts observed across a sample of ~300 executives in 2025–2026 and corroborated against public industry data from the FBI, FTC, and Verizon DBIR, the research exposes a structural gap in enterprise security: the most public-facing people in an org...
-
DDN Unveils Infinia 2.4 at RAISE, Establishing an Enterprise Foundation for Production AI, Inference Economics, and Sovereign AI Factories
PARIS--(BUSINESS WIRE)--DDN, the global leader in AI and data intelligence solutions, today announced the launch of DDN Infinia 2.4 at the RAISE Summit in Paris, extending the industry's leading platform for production AI, large-scale inference, and sovereign AI infrastructure.As AI moves from training models to operating intelligent systems in production, enterprises face a new challenge: maximizing the economic return of AI infrastructure investments. The bottleneck is no longer acquiring GPUs...
-
N-able Earns Comparably Recognition for HR and Marketing Teams
BURLINGTON, Mass.--(BUSINESS WIRE)--N-able, Inc. (NYSE: NABL), a global cybersecurity company delivering business resilience, today announced a series of workplace and people-focused awards.N-able earned two Comparably awards, Best HR Teams 2026 and Best Marketing Teams 2026, based on employee sentiment and leadership benchmarks. These recognitions reflect a culture grounded in strong leadership, transparency, and a shared commitment to ensuring employees feel valued, included, and empowered. As...
-
Powerlaw Corp. (Nasdaq: PWRL) Highlights OpenAI Holding as Reports Suggest IPO Delayed Until 2027
SAN FRANCISCO--(BUSINESS WIRE)--Powerlaw Corp. (Nasdaq: PWRL), a publicly traded closed-end fund advised by Powerlaw Fund Adviser, LLC, today highlights its pre-IPO exposure to portfolio company OpenAI, which filed confidential paperwork for a potential initial public offering earlier this month. Recent reports indicate that the company may delay its IPO until 2027.“We backed OpenAI across three tranches starting in spring 2025,” said Ben Black, Chief Investment Officer of PWRL. “Since PWRL inve...
-
TIXiMED Initiates Phase 1b Multiple Ascending Dose Study of TIX100
BIRMINGHAM, Ala.--(BUSINESS WIRE)--TIXiMED, Inc. (www.TIXiMED.com), a clinical-stage pharmaceutical company developing a novel disease-modifying oral therapy for type 1 diabetes (T1D), today announced the initiation of the Phase 1b Multiple Ascending Dose (MAD) study of TIX100 (NCT07675590), an investigational oral inhibitor of thioredoxin-interacting protein (TXNIP). The TIX100 MAD study is a double-blind, randomized, placebo-controlled trial evaluating the safety, tolerability, and pharmacoki...
-
Allocate Expands Leadership Team Amid Rapid Growth, Appoints Matt Dunn as Chief Revenue Officer
SAN FRANCISCO--(BUSINESS WIRE)--Allocate, the private markets operating system for wealth advisory firms and fund managers, today announced the appointment of Matt Dunn as Chief Revenue Officer (CRO). A veteran of PIMCO, Morgan Stanley, and Opto Investments, Dunn's role follows a series of strategic senior hires as Allocate scales to meet surging demand for modern private markets infrastructure. The appointment comes amid significant momentum for Allocate. Over the past year, the company has gr...